These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7733005)

  • 21. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
    Pasternak RC; Brown LE; Stone PH; Silverman DI; Gibson CM; Sacks FM
    Ann Intern Med; 1996 Oct; 125(7):529-40. PubMed ID: 8815751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gender bias in lipid assessment and treatment following percutaneous coronary intervention.
    Corbelli JA; Corbelli JC; Bullano MF; Willey VJ; Cziraky MJ; Banks LD; Cooke BE; Galla AM; Berchou KA; Drury CJ
    J Gend Specif Med; 2003; 6(3):21-6. PubMed ID: 14513572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of restenosis by bezafibrate after successful coronary angioplasty.
    Ishiwata S; Nakanishi S; Nishiyama S; Seki A
    Coron Artery Dis; 1995 Nov; 6(11):883-9. PubMed ID: 8696533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low high density lipoprotein level is associated with increased restenosis rate after coronary angioplasty.
    Shah PK; Amin J
    Circulation; 1992 Apr; 85(4):1279-85. PubMed ID: 1555271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Lipid risk factors of coronary heart disease during longterm observation of a Warsaw Pol-Monica population-based cohort].
    Chotkowska E; Jasiński B; Kupść W; Broda G
    Pol Arch Med Wewn; 1997 Jan; 97(1):37-46. PubMed ID: 9235550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High serum concentration of lipoprotein(a) is a risk factor for restenosis after percutaneous transluminal coronary angioplasty in Japanese patients with single-vessel disease.
    Miyata M; Biro S; Arima S; Hamasaki S; Kaieda H; Nakao S; Kawataki M; Nomoto K; Tanaka H
    Am Heart J; 1996 Aug; 132(2 Pt 1):269-73. PubMed ID: 8701886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Lipids, lipoproteins and apolipoproteins in normal newborns].
    Casanueva V; Cid X; Chiang MT; Molina M; Ferrada MC; Pérez R; Casanueva P
    Rev Med Chil; 1998 Sep; 126(9):1073-8. PubMed ID: 9922510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibrinogen values in patients with and without restenosis following percutaneous transluminal coronary angiography.
    Schumacher M; Eber B; Tiran A; Toplak H; Luha O; Gasser R; Klein W
    Cardiology; 1992; 80(5-6):345-8. PubMed ID: 1451121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Correlation between serum lipid level and coronary bed lesions in patients with ischemic heart disease].
    Buslenko NS; Beliavskiĭ VI; Saprygin DB; Mironenko AE; Krashutskiĭ VV
    Kardiologiia; 1984 Nov; 24(11):28-32. PubMed ID: 6596456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Relation between the lipid picture and coronary artery disease documented angiographically].
    Binaghi F; Valle E; Manconi E; Martelli V; Pitzus F
    Minerva Cardioangiol; 1985 Sep; 33(9):547-52. PubMed ID: 4088482
    [No Abstract]   [Full Text] [Related]  

  • 31. The lipoprotein fraction between VLDL and LDL detected by biphasic agarose gel electrophoresis reflects serum remnant lipoprotein and Lp(a) concentrations.
    Sato I; Taniguchi T; Ishikawa Y; Kusuki M; Hayashi F; Mukai M; Kawano S; Kondo S; Yamashita S; Kumagai S
    J Atheroscler Thromb; 2006 Feb; 13(1):55-61. PubMed ID: 16505592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Serum lipids of alcoholics before and following abstinence. Significance for coronary risk].
    Clemens MR; Schied HW; Waller HD
    J Clin Chem Clin Biochem; 1986 Jun; 24(6):369-74. PubMed ID: 3746201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of cholesterol levels and occurrence of angiographically detectable endothelial disruption during coronary angioplasty.
    Rubboli A; Euler DE; Sangiorgio P; Casella G; La Vechia L; Fontanelli A; Bracchetti D
    Clin Cardiol; 2003 Jul; 26(7):336-40. PubMed ID: 12862300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholesterol guidelines, lipoprotein cholesterol levels, and triglyceride levels: potential for misclassification of coronary heart disease risk.
    Laemmle P; Unger L; McCray C; Chalin M; Glueck CJ
    J Lab Clin Med; 1989 Mar; 113(3):325-34. PubMed ID: 2926240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Coronary heart disease and lipoprotein (a): relationship with other lipid cardiovascular risk factors].
    Nogués X; Sentí M; Pedro-Botet J; Molina L; Serrat R; Pons S; Rubiés-Prat J
    Med Clin (Barc); 1992 Feb; 98(5):171-4. PubMed ID: 1532436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of serum cholesterol and cholesterol subfractions on restenosis following successful coronary intervention.
    Violaris AG; Ismail TF; El-Gendi H; Foale RA
    Semin Interv Cardiol; 1999 Sep; 4(3):111-9. PubMed ID: 10545617
    [No Abstract]   [Full Text] [Related]  

  • 37. Restenosis after elective coronary balloon angioplasty in patients with end stage renal disease: a case-control study using quantitative coronary angiography.
    Schoebel FC; Gradaus F; Ivens K; Heering P; Jax TW; Grabensee B; Strauer BE; Leschke M
    Heart; 1997 Oct; 78(4):337-42. PubMed ID: 9404246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for restenosis after percutaneous transluminal coronary angioplasty: role of lipoprotein (a).
    Yamamoto H; Imazu M; Yamabe T; Ueda H; Hattori Y; Yamakido M
    Am Heart J; 1995 Dec; 130(6):1168-73. PubMed ID: 7484765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The risk of coronary heart disease in men with androgenetic alopecia.
    Sasmaz S; Senol M; Ozcan A; Dogan G; Tuncer C; Akyol O; Sener S
    J Eur Acad Dermatol Venereol; 1999 Mar; 12(2):123-5. PubMed ID: 10343940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rationale for use of non-high-density lipoprotein cholesterol rather than low-density lipoprotein cholesterol as a tool for lipoprotein cholesterol screening and assessment of risk and therapy.
    Frost PH; Havel RJ
    Am J Cardiol; 1998 Feb; 81(4A):26B-31B. PubMed ID: 9526810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.